Offering more than 150 oncology-specific tests in nine subspecialty areas, Mayo Clinic Laboratories’ cancer tests are developed by an experienced team of board-certified geneticists, genetic counselors, and physicians. Each assay is validated in collaboration with Mayo Clinic oncologists, pathologists, and laboratorians, whose clinical expertise enables test options that improve patient care and increase efficiency.

Mayo Clinic Laboratories innovates at the speed of medical advancement and offers full-spectrum testing across the oncological arena. From broad, next-generation sequencing (NGS) panels like MayoComplete, which examines more than 500 genes for variations associated with solid tumors; to advanced fluorescence in situ hybridization (FISH) testing for monitoring chronic lymphocytic leukemia; to polymerase chain reaction (PCR) for single gene evaluation; our molecular and cytogenetic assays span the oncological spectrum, providing insights on common and rare disease to advance clinical trials and therapeutic development.

Test menu

Comprehensive disease testing

In addition to accessing our clinically available tests, BioPharma Diagnostics partners can access oncological testing for clinical trials and be among the first to use up-and-coming tests currently in development.

  • Disease-specific NGS panels for somatic tumors, including panels specific to neuro-oncology, sarcoma, lung, colorectal, gastrointestinal stromal cancers, and more
  • MayoComplete Solid Tumor Panel, which uses NGS to evaluate 514 genes
  • Hereditary oncology NGS panels for germline assessment
  • 50+ single gene assays using FISH and PCR
  • Single gene cell-free DNA testing
  • Immunohistochemistry
  • Chromosomal microarray
  • Methylation analysis for MGMT
News and updates

The latest

View More

Fill out the form below and one of our specialists will be in touch.